Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice-Reference-Cited by-同舟云学术

Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice

Published:2024-05 Issue:3 Volume:4 Page:100442
ISSN:2666-9145
Container-title:Ophthalmology Science
language:en
Short-container-title:Ophthalmology Science

Author:

Guymer Robyn^ORCID,Bailey Clare,Chaikitmongkol Voraporn,Chakravarthy Usha^ORCID,Chaudhary Varun^ORCID,Finger Robert P.,Gallego-Pinazo Roberto,Chuan Adrian Koh Hock,Ishida Susumu,Lövestam-Adrian Monica^ORCID,Parravano Mariacristina,Luna Pinto Jose D.,Schmitz-Valckenberg Steffen^ORCID,Sheth Veeral^ORCID,Souied Eric H.,Chi Gloria C.^ORCID,Gilberg Frank,Glittenberg Carl,Scheidl Stefan,Bengus Monica

Funder

F Hoffmann-La Roche Ltd

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Ophthalmology

Reference34 articles.

1. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems;Finger;BMC Ophthalmol,2020

2. Visual impairment and blindness avoided with ranibizumab in Hispanic and non-Hispanic Whites with diabetic macular edema in the United States;Varma;Ophthalmology,2015

3. Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis;Li;Eur J Epidemiol,2020

4. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob Health,2014

5. Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States;Ciulla;Ophthalmol Retina,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration;British Journal of Ophthalmology;2024-07-20